Literature DB >> 16134601

[Changes of plasma CD62p levels in patients with acute cerebral infarction].

Xiao-Song Huang1, Qi-Dong Yang, Yun-Hai Liu, Zun-Jing Liu.   

Abstract

OBJECTIVE: To explore the function of CD62p in cerebral infarction and the relation between the changes of its level and the severity and recovery of cerebral infarction, MPV, PDW and PLT by studying the changes of the levels of plasma CD62p in patients with acute cerebral infarction.
METHODS: The levels of plasma CD62p were measured by ELISA in 60 patients at 48 hours, 6 - 8 days and 15 days after ischemia, and at the same time, we evaluated neurological function deficiency score and measured MPV, PDW and PLT. The levels of 30 healthy persons mating cerebral infarction group in both sex and ages were measured.
RESULTS: The levels of plasma CD62p in the patients with acute cerebral infarction were obviously higher than the levels of the healthy controls (P < 0.001). The levels of plasma CD62 p in CI group at 48 hours postischemia were higher than the levels at 6 - 8 days and at 15 days with obvious difference (P <0.01). The levels of plasma CD62p in the medium and the severe SSS patients were higher than the levels of the lights (P <0.001). The levels of plasma CD62p were positively correlated with SSS, MPV and PDW (r = 0.61, 0.51, 0.47, P < 0.01), and negatively correlated with PLT (r = -0.32, P < 0.01).
CONCLUSION: CD62p may participate in acute cerebral infarction and play a crucial role, and the change of its levels correlates with SSS, MPV, PDW and Plt.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16134601

Source DB:  PubMed          Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-7347


  2 in total

1.  Haemostatic parameters, platelet activation markers, and platelet indices among regular plateletpheresis donors.

Authors:  Hulwani T M Tuan; Lim S Hock; Zaidah W Abdullah
Journal:  J Taibah Univ Med Sci       Date:  2017-12-01

2.  The Value of Combined Detection of D-dimer and CD62p in Judging the Severity of Acute Cerebral Infarction and Short-Term Prognosis.

Authors:  Min Xu; Xiao-Ying He; Pan Huang
Journal:  Biomed Res Int       Date:  2021-01-14       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.